METILDA

• Research type

  Research Study

• Full title

  A Randomised Phase II Study in Metastatic Melanoma to Evaluate the Efficacy of Adoptive Cellular Therapy with Tumour Infiltrating Lymphocytes (TIL) and Assessment of High versus Low Dose Interleukin-2

• IRAS ID

  124300

• Contact name

  RE Hawkins

• Contact email

  RHawkins@PICR.man.ac.uk

• Sponsor organisation

  The Christie NHS Foundation Trust

• Eudract number

  2013-001071-20

• REC name

  Scotland A REC

• REC reference

  13/SS/0168

• Date of REC Opinion

  23 Oct 2013

• REC opinion

  Further Information Favourable Opinion